Accès ouvert
2026
supplementary-materials
OpenAlex
Tolulope Adewole, Björn Albrecht, Shaalan Beg, Otis Brawley et autres
Supplementary Figure 1: Number of cancer cases and deaths across indications in 2020, Millions
Accès ouvert
2024
supplementary-materials
OpenAlex
Tolulope Adewole, Björn Albrecht, Shaalan Beg, Otis W. Brawley et autres
Supplementary Table 1: Authors and affiliations
Accès ouvert
2024
other
OpenAlex
Tolulope Adewole, Björn Albrecht, Shaalan Beg, Otis W. Brawley et autres
Summary: Despite exponentially increased industry investment in oncology research and development with more than $80 billion spent annually, patient enrollment in clinical trials remains below 5% globally. Our multistakeholder international cancer coalition envisions ecosystem transformation with capacity building through a global “hub-and-spoke” …
Accès ouvert
2024
supplementary-materials
OpenAlex
Tolulope Adewole, Björn Albrecht, Shaalan Beg, Otis W. Brawley et autres
Supplementary Figure 2: Number of cancer cases and deaths across geography in 2020, Millions
Accès ouvert
2024
supplementary-materials
OpenAlex
Tolulope Adewole, Björn Albrecht, Shaalan Beg, Otis W. Brawley et autres
Supplementary Figure 1: Number of cancer cases and deaths across indications in 2020, Millions
Accès ouvert
2024
article
OpenAlex
Tolulope Adewole, Björn Albrecht, Shaalan Beg, Otis W. Brawley et autres
Despite exponentially increased industry investment in oncology research and development with more than $80 billion spent annually, patient enrollment in clinical trials remains below 5% globally. Our multistakeholder international cancer coalition envisions ecosystem transformation with capacity building through a global "hub-and-spoke" network …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Bobby Daly, Otis W. Brawley, Mary Gospodarowicz, Olufunmilayo I. Olopade et autres
Importance: Less than 5% of patients with cancer enroll in a clinical trial, partly due to financial and logistic burdens, especially among underserved populations. The COVID-19 pandemic marked a substantial shift in the adoption of decentralized trial operations by pharmaceutical companies. Objective: …
us, ca, cn, ch, gb, de
(code pays fourni par la source)
1958
article
OpenAlex
Harriet Keane